Research & Development
Calibre Scientific, Aegis Sciences announce diagnostic industry acquisitions
Calibre Scientific has acquired Glass Chemicals, a Spanish distributor of scientific consumables, equipment, and services for the life sciences and industrial sectors as well as diagnostics.
January 17, 2023
Lab owner pleads guilty to fraud charge for genetic tests
Federal investigators said that Christopher Licata pleaded guilty to paying patient brokers to secure referrals from doctors for orders authorizing medically unnecessary genetic testing to Licata's laboratory, Boca Toxicology (dba Lab Dynamics). Licata and his lab would then bill Medicare for the tests, according to authorities.
January 13, 2022
Labcorp to buy Toxikon
Once completed, the acquisition will create a strategic footprint for Labcorp to partner with pharmaceutical and biotechnology clients in the Boston area and bolster its strong nonclinical development portfolio, company representatives said.
November 17, 2021
Thermo Fisher Scientific teams up with Mindray
Thermo Fisher will offer Mindray's BS-480 and BA-800M analyzers to toxicology labs. BS-480 can provide 400 tests per hour, while BA-800M can perform 800 tests per hour, according to the vendors.
February 9, 2021
CompuGroup Medical acquires Schuyler House
The deal also adds Schuyler House's SchuyLab laboratory information system to CompuGroup's portfolio. SchuyLab features a modular and scalable software designed for physician offices and reference laboratories.
December 6, 2020
Head of Tenn. drug testing lab hit with $9M fine
Michael Norman Dube and his wife Regan Gran Dube pleaded guilty to charges of healthcare fraud in connection with their drug testing company, American Toxicology Labs. The company specialized in performing urine screens for various entities that claimed to be opioid treatment facilities, according to federal investigators.
June 25, 2020
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
Fentanyl during moms' labor shows up in babies' urine
The investigators evaluated urine toxicology screening results from 96 newborns, using a review of medical records, which included the type and level of anesthesia administered to mothers during labor. Of the total, 29% of neonatal samples were positive for fentanyl, reported Athena Petrides, PhD, an assistant professor of pathology at Brigham and Women's Hospital and Harvard Medical School, and colleagues.
March 24, 2020
MedTest Dx to launch new Clinitox line at AACC 2019
Targeted at labs that perform confirmation testing, the new Clinitox Calibrators and Controls line is designed to eliminate the need to acquire and set up materials, perform multiple handling and measuring steps, and manage controls and certifications.
July 31, 2019
Antiopioid law could criminalize sales commissions for clinical lab patient referrals
The legislation, called the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, was originally intended to battle the U.S. opioid crisis when passed in 2018. But the bill also has an all-payor kickback prohibition that applies to laboratories, recovery homes, and clinical treatment facilities. This prohibition applies to all laboratory business arrangements covered by all payors -- not just government but also commercial -- and to all types of testing, not just to labs undertaking opioid-related toxicology testing.
April 17, 2019
Micro-CT, blood test aid early lung cancer detection
The researchers from the U.K. acquired, at several different time points, micro-CT scans of mice that had precancerous lung tumors because of a mutation in the KRAS gene. They collected blood samples at the same time intervals to track the levels of total circulating cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) in the mice.
February 13, 2019
Page 1 of 1